Yıl: 2015 Cilt: 32 Sayı: 1 Sayfa Aralığı: 73 - 76 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Successful Off-Label Use of Recombinant Factor VIIa and Coil Embolization in an Adolescent with Massive Hemoptysis Due to Invasive Pulmonary Aspergillosis

Öz:
İnvaziv fungal enfeksiyonlar pediatrik malin hastalıklarda morbidite ve mortalitenin önemli bir nedenidir. Masif hemoptizi de sıklıkla nötropenin düzelme aşamasında görülen, invaziv pulmoner aspergillozisin hayatı tehdit edici nadir bir komplikasyonudur. Bu yazıda invaziv pulmoner aspergillozise bağlı masif hemoptizi gelişen bir hastada endikasyon dışı recombinant FVIIa kullanımı ardından sağ pulmoner artere coil embolizasyon uygulanarak kanama kontrolu sağlanan bir olgu sunulmuştur. Anahtar Sözcükler:
Anahtar Kelime:

Konular: Hematoloji

İnvaziv Pulmoner Aspergillozise Bağlı Masif Hemoptizi Görülen Adölesan Bir Hastada, Endikasyon Dışı Rekombinan Faktör VIIa nın ve Coil Emobolizasyonunun Başarılı Kullanımı

Öz:
Abstract: Invasive fungal infections have turned out to be a significant cause of morbidity and mortality in pediatric patients with malignant disorders. Massive hemoptysis, a rare complication of invasive pulmonary aspergillosis, may threaten the lives of patients, usually during the resolution of neutropenia. In this report, we describe a patient with massive hemoptysis due to invasive pulmonary aspergillosis whose bleeding was controlled successfully with off-label use of recombinant factor VIIa and subsequent coil embolization of the right pulmonary artery. Key Words:
Anahtar Kelime:

Konular: Hematoloji
Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
  • 1. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011;52:56-93.
  • 2. Azap A, Bozkurt GY, Yüksel MK, Kutlu H, Topçuoğlu P, Aypak A, Akan H. Secondary infections in cancer patients with febrile neutropenia. Turk J Hematol 2012;29:254-258.
  • 3. de Pauw BE, Viscoli C. Managing invasive fungal infections: relying on clinical instincts or on a rational navigation system? J Antimicrob Chemother 2011;66:55-58.
  • 4. Albelda SM, Talbot GH, Gerson SL, Miller WT, Cassileth PA. Pulmonary cavitation and massive hemoptysis in invasive pulmonary aspergillosis. Am Rev Respir Dis 1985;131:115- 120.
  • 5. Avci Z, Alioglu B, Anuk D, Ozbek OY, Azap OK, Ozbek N. Double invasive fungal infection and typhlitis in children with acute lymphoblastic leukemia. Pediatr Hematol Oncol 2008;25:99-106.
  • 6. Caillot D, Casasnovas O, Bernard A, Couaillier JF, Durand C, Cuisenier B, Solary E, Piard F, Petrella T, Bonnin A, Couillault G, Dumas M, Guy H. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997;15:139-147.
  • 7. Johnson JL. Manifestations of hemoptysis. Postgrad Med 2002;112:101-106.
  • 8. Yoon W. Embolic agents used for bronchial artery embolization in massive haemoptysis. Expert Opin Pharmacother 2004;5:361-367.
  • 9. Jean-Baptiste E. Clinical assessment and management of massive hemoptysis. Crit Care Med 2000;28:1642-1647.
  • 10. Pagano L, Ricci P, Nosari A, Tonso A, Buelli M, Montillo M, Cudillo L, Cenacchi A, Savignana C, Melillo L. Fatal haemoptysis in pulmonary filamentous mycosis: an underevaluated cause of death in patients with acute leukemia in haematological complete remission. A retrospective study and review of the literature. Gimema Infection Program (Gruppo Italiano Malattie Ematologiche dell’Adulto). Br J Haematol 1995;89:500-505.
  • 11.Denning DW. Invasive aspergillosis. Clin Infect Dis 1998;26:781-805.
  • 12. Lordon JL, Gascoigne A, Corris PA. The pulmonary physician in critical care • Illustrative case 7: assessment and management of massive haemoptysis. Thorax 2003;58:814- 819.
  • 13. Bain J, Lewis D, Bernard A, Hatton K, Reda H, Flynn J. Implementation of an off-label recombinant factor VIIa protocol for patients with critical bleeding at an academic medical center. J Thromb Thrombolysis 2014;38:447-452.
  • 14. Levy JH, Fingerhut A, Brott T, Langbakke IH, Erhardtsen E, Porte RJ. Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile. Transfusion 2006;46:919-933.
  • 15. Samarzija M, Srdic D, Redzepi G, Plestina S, Mazuranic I, Jakopovic M, Miculinic N. Recombinant factor VIIa in massive haemoptysis associated with chronic necrotising aspergillosis. Coll Antropol 2008;32:999-1002.
  • 16. Mitrovic M, Elezovic I, Suvajdzic-Vukovic N, Antic D. Successful non-standard approaches to massive hemoptysis in invasive pulmonary aspergillosis. Srp Arh Celok Lek 2012;140:505-507.
  • 17. Remy J, Voisin C, Ribet M. Treatment, by embolization, of severe or repeated hemoptysis associated with systemic hypervascularization. Nouv Presse Med 1973;2:2060-2068 (article in French).
  • 18.Khalil A, Fartoukh M, Bazot M, Parrot A, Marsault C, Carette MF. Systemic arterial embolization in patients with hemoptysis: initial experience with ethylene vinyl alcohol copolymer in 15 cases. Am J Roentgenol 2010;194:104-110.
  • 19.Chapman SA, Holmes MD, Taylor DJ. Unilateral diaphragmatic paralysis following bronchial artery embolization. Chest 2001;118:269-270.
  • 20.Dohen-Bécue F, Salez F, Ramon P, Leblond-Tillie I, Wallaert B, Bauters A, Tonnel AB. Management of hemoptysis in invasive pulmonary aspergillosis. Rev Mal Respir 1998;15:791-796 (article in French with English abstract).
APA Gurlek Gokcebay D, Fettah A, KIRBAŞ İ, TUNÇ B, ozbek n (2015). Successful Off-Label Use of Recombinant Factor VIIa and Coil Embolization in an Adolescent with Massive Hemoptysis Due to Invasive Pulmonary Aspergillosis. , 73 - 76.
Chicago Gurlek Gokcebay Dilek,Fettah Ali,KIRBAŞ İsmail,TUNÇ Bahattin,ozbek namik yasar Successful Off-Label Use of Recombinant Factor VIIa and Coil Embolization in an Adolescent with Massive Hemoptysis Due to Invasive Pulmonary Aspergillosis. (2015): 73 - 76.
MLA Gurlek Gokcebay Dilek,Fettah Ali,KIRBAŞ İsmail,TUNÇ Bahattin,ozbek namik yasar Successful Off-Label Use of Recombinant Factor VIIa and Coil Embolization in an Adolescent with Massive Hemoptysis Due to Invasive Pulmonary Aspergillosis. , 2015, ss.73 - 76.
AMA Gurlek Gokcebay D,Fettah A,KIRBAŞ İ,TUNÇ B,ozbek n Successful Off-Label Use of Recombinant Factor VIIa and Coil Embolization in an Adolescent with Massive Hemoptysis Due to Invasive Pulmonary Aspergillosis. . 2015; 73 - 76.
Vancouver Gurlek Gokcebay D,Fettah A,KIRBAŞ İ,TUNÇ B,ozbek n Successful Off-Label Use of Recombinant Factor VIIa and Coil Embolization in an Adolescent with Massive Hemoptysis Due to Invasive Pulmonary Aspergillosis. . 2015; 73 - 76.
IEEE Gurlek Gokcebay D,Fettah A,KIRBAŞ İ,TUNÇ B,ozbek n "Successful Off-Label Use of Recombinant Factor VIIa and Coil Embolization in an Adolescent with Massive Hemoptysis Due to Invasive Pulmonary Aspergillosis." , ss.73 - 76, 2015.
ISNAD Gurlek Gokcebay, Dilek vd. "Successful Off-Label Use of Recombinant Factor VIIa and Coil Embolization in an Adolescent with Massive Hemoptysis Due to Invasive Pulmonary Aspergillosis". (2015), 73-76.
APA Gurlek Gokcebay D, Fettah A, KIRBAŞ İ, TUNÇ B, ozbek n (2015). Successful Off-Label Use of Recombinant Factor VIIa and Coil Embolization in an Adolescent with Massive Hemoptysis Due to Invasive Pulmonary Aspergillosis. Turkish Journal of Hematology, 32(1), 73 - 76.
Chicago Gurlek Gokcebay Dilek,Fettah Ali,KIRBAŞ İsmail,TUNÇ Bahattin,ozbek namik yasar Successful Off-Label Use of Recombinant Factor VIIa and Coil Embolization in an Adolescent with Massive Hemoptysis Due to Invasive Pulmonary Aspergillosis. Turkish Journal of Hematology 32, no.1 (2015): 73 - 76.
MLA Gurlek Gokcebay Dilek,Fettah Ali,KIRBAŞ İsmail,TUNÇ Bahattin,ozbek namik yasar Successful Off-Label Use of Recombinant Factor VIIa and Coil Embolization in an Adolescent with Massive Hemoptysis Due to Invasive Pulmonary Aspergillosis. Turkish Journal of Hematology, vol.32, no.1, 2015, ss.73 - 76.
AMA Gurlek Gokcebay D,Fettah A,KIRBAŞ İ,TUNÇ B,ozbek n Successful Off-Label Use of Recombinant Factor VIIa and Coil Embolization in an Adolescent with Massive Hemoptysis Due to Invasive Pulmonary Aspergillosis. Turkish Journal of Hematology. 2015; 32(1): 73 - 76.
Vancouver Gurlek Gokcebay D,Fettah A,KIRBAŞ İ,TUNÇ B,ozbek n Successful Off-Label Use of Recombinant Factor VIIa and Coil Embolization in an Adolescent with Massive Hemoptysis Due to Invasive Pulmonary Aspergillosis. Turkish Journal of Hematology. 2015; 32(1): 73 - 76.
IEEE Gurlek Gokcebay D,Fettah A,KIRBAŞ İ,TUNÇ B,ozbek n "Successful Off-Label Use of Recombinant Factor VIIa and Coil Embolization in an Adolescent with Massive Hemoptysis Due to Invasive Pulmonary Aspergillosis." Turkish Journal of Hematology, 32, ss.73 - 76, 2015.
ISNAD Gurlek Gokcebay, Dilek vd. "Successful Off-Label Use of Recombinant Factor VIIa and Coil Embolization in an Adolescent with Massive Hemoptysis Due to Invasive Pulmonary Aspergillosis". Turkish Journal of Hematology 32/1 (2015), 73-76.